Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Agere Pharmaceuticals

Agere Pharmaceuticals
2008 FOUNDED
M&A STATUS
51-60 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company specializes in improving the oral bioavailability of BCS II - IV compounds through fundamental science, solubilization expertise, and proprietary solubilization technologies.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 62925 NorthEast 18th Street
  • Bend, OR 97701
  • United States

Agere Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Agere Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Agere Pharmaceuticals Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ziopharm Oncology Corporation Boston, MA 00 00000 000000000 00000
000000 00000000000 Corporation PA 000 000.00 0000000000 000.00
To view this company’s complete list of competitors, request access »

Agere Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Marshall Crew Ph.D President & Chief Executive Officer
Casey Jones Vice President, Corporate Development
Michael Deperro Vice President, Operations